News & Insights
Sort By
Client News 7 Results
Client News
|February 13, 2025
Newleos Therapeutics Announces $93.5M Series A for Next Generation Mental Health Therapies
Clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, Newleos Therapeutics, announces its $93.5 million Series A financing
Client News
|December 18, 2024
Proximity-based therapeutics company, Photys Therapeutics, announces its multi-year collaboration and license agreement with Novo Nordisk
Client News
|October 16, 2024
Lightmatter Announces $400M Series D and $4.4B Valuation
Leader in photonic supercomputing, Lightmatter, announces its $400 million Series D financing led by T. Rowe Price Associates, Inc.
Firm News 2 Results
Firm News
|March 1, 2024
Gunderson Dettmer Commemorates 2024 Women's History Month and International Women's Day
Gunderson Dettmer Women's Affinity Group features the Women's History Month and International Women’s Day 2024 theme, “Count Her In: Invest in Women. Accelerate Progress” with a series of events across its US offices, access to resources and tribute to achievements and progress of women.
Firm News
|March 8, 2023
Gunderson Dettmer Celebrates 2023 Women's History Month and International Women's Day
Gunderson Dettmer commemorates Women's History Month and International Women's Day in March 2023 with a series of events across its US offices, access to resources and tribute to this month's theme, #EmbraceEquity